- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 197.84M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $321.86M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $321.43M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $33.36M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $37.79M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $108.13M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $99.85M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $457.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $351.85M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $786.62M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $681.11M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $774.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $661.64M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $895.62M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $782.06M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $432.86M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $238.9M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 189.01M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $11.12M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.24M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.25 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.25 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $90.51M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$46.52M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$41.11M |